October 2024 - Page 2 of 2 - BioMedWire (BMW)

MondayOct 14, 2024 10:00 am

Researchers Shine Spotlight on New Barriers to Vaccination

The 20th century saw many advancements being adopted in the medical field, among them, potable water, penicillin and, most importantly, vaccines. Vaccines have saved millions of lives, from the eradication of smallpox globally in the 1980s to their use in curbing the spread of the coronavirus in 2020. Over the last 10 years, however, rates of vaccination have begun to drop, threatening the great beneficial effects of vaccinations not only in the United States but also around the globe. A recent review examined the new public health and clinical barriers to vaccination in the United States. The review was conducted…

FridayOct 11, 2024 10:00 am

Siblings of Autistic Kids Have Sevenfold Higher Risk of Autism

Autism spectrum disorder is a developmental and neurological disorder that affects how an individual communicates and interacts with others as well as the individual behaves and learns. Now, a new study has determined that siblings of children with autism have a higher likelihood of being diagnosed with the developmental disorder. The research was carried out by researchers from the Baby Siblings Research Consortium and the UC Davis MIND Institute. The researchers’ objective was to determine the likelihood that a child born after an autistic child in one family would have the disorder. Huge increases in autism diagnoses, as observed in…

ThursdayOct 10, 2024 11:15 am

Clene Inc. (NASDAQ: CLNN) Closes $7.3 Million Registered Direct Offering and Concurrent Private Placements

Proceeds from the offerings will support the company’s operations into the first quarter of 2025. Clene also amended its existing debt facility with Avenue Venture Opportunities Fund, L.P. to reduce or defer future monthly principal payments and to extend principal amortization period and the final maturity date into the first half of 2025. The company’s lead drug candidate, CNM-Au8® has been shown to restore and protect neurological function, offering new hope for patients with ALS and other neurodegenerative conditions. Clene is seeking an accelerated approval pathway for CNM-Au8 for ALS, with a meeting scheduled with the FDA before the end…

WednesdayOct 09, 2024 10:00 am

Eight New e-Commerce Tools Businesses Can Leverage

Businesses seeking to grow their sales may benefit from e-commerce tools that reduce their workloads while making it easier for their products to reach consumers. We discuss new e-commerce tools that businesses can leverage, below. Supply chain by Amazon Amazon recently rolled out its supply chain service, which allows Amazon to automate and manage product movement for sellers. To access this service, sellers only have to provide pick-up locations and product details, leaving Amazon to handle things such as the consolidation of inventory, carrier pickup and optimization based on costs, inventory and demand. Cross-border ecommerce platform DHL Global Forwarding recently…

TuesdayOct 08, 2024 9:45 am

Astiva Health Inc. Integrates Key Medicare Components into Single Plan, Making It Easier to Manage Healthcare, Access Resources

This year enrollment in Medicare Advantage plans reached 32.8 million members, representing 52% of all Medicare recipients. Medicare Advantage plans typically integrate various health services under one umbrella. Astiva Health’s approach helps members manage existing health conditions and also focuses on promoting overall wellness. Over the past two decades, Medicare Advantage has transformed from a niche option into a primary choice for millions of seniors across the United States. Medicare Advantage plans bundle Part A, Part B and sometimes Part D coverage into one plan, along with often offering extra benefits that original Medicare doesn't cover. A fast-growing Medical Advantage…

MondayOct 07, 2024 10:00 am

At Least 14 Million Americans Affected by Data Breaches in Healthcare

A brief generated by a cybersecurity company has revealed that nearly 14 million patients in the United States have been affected by breaches in healthcare data thus far this year. The report also found that 91% of the breaches involved ransomware, which calls attention to the targeting of the country’s healthcare sector. SonicWall based the report it generated on data from Capture Labs, which utilizes machine learning to gather and retain data on threats and attack vectors in real time. The researchers’ analysis highlighted an increasing prominence of ransomware actors that specialized in targeting healthcare, such as ALPHV/BlackCat and LockBit.…

FridayOct 04, 2024 11:15 am

Annovis Bio Inc. (NYSE: ANVS) Seeking to Strengthen Intellectual Property Portfolio, Protecting Multifaceted Approach for Treatment of Neurodegenerative Diseases

Annovis Bio recently filed three new patents covering combinations of buntanetap, its lead compound, with a GLP-1 agonist (such as dulaglutide/Trulicity) and with PDE5 inhibitors (such as sildenafil/Viagra), as well as a combination of all three The company believes these combinations create a broader approach to treating neurodegenerative diseases Preclinical studies have demonstrated these combinations significantly improve cognition in Alzheimer’s mouse models Combinations of buntanetap with PDE5 inhibitors and GLP-1 agonists are now ready to enter phase 3 clinical studies (buntanetap is in phase 3, and a number of PDE5 inhibitors and GLP-1 agonists are already on the market) Annovis…

FridayOct 04, 2024 10:00 am

Jimmy Carter Survival Thanks to Novel Cancer Immunotherapy Treatment

In August 2015, former president Jimmy Carter revealed at a conference held at the Carter Center that cancer had spread to his brain. Carter, then aged 91, discussed how his initial diagnosis of melanoma had led to the disease’s spread. If he had been diagnosed with the illness just a few years prior, he would have had about six months to live. Instead, the former president celebrated his 100th birthday on Oct. 1, 2024. While luck did play a role, experts believe Carter is alive today because of immunotherapy treatments. At the time, immunotherapy was a new treatment following the…

WednesdayOct 02, 2024 10:00 am

Disruptions in Purine Metabolism Cited in Parkinson’s Development

Parkinson’s disease is a neurodegenerative condition that affects an individual’s brain, causing issues with their movement, sleep and mental health. Common symptoms include tremors, slowed movements and issues with balance. For years, researchers have observed reduced uric acid levels in Parkinson’s disease patients. Uric acid is created when the human body breaks down purines, which are produced in the body. In the past, scientists posited that uric acid, which possesses antioxidant properties, played a role in decreasing oxidative stress in the brain. Now, new research has unveiled new insights into how patients with Parkinson’s disease suffer metabolic disruptions. Scientists began…